ID   NMD3A_RAT               Reviewed;        1135 AA.
AC   Q9R1M7; O09098; O09155; Q62800; Q63268; Q9Z2H0;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   02-OCT-2024, entry version 164.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 3A;
DE            Short=GluN3A;
DE   AltName: Full=Glutamate receptor chi-1;
DE   AltName: Full=N-methyl-D-aspartate receptor;
DE   AltName: Full=N-methyl-D-aspartate receptor subtype 3A;
DE            Short=NMDAR3A;
DE            Short=NR3A;
DE   AltName: Full=NMDAR-L;
DE   AltName: Full=NMDAR-L1;
DE   Flags: Precursor;
GN   Name=Grin3a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), CHARACTERIZATION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain stem, and Spinal cord;
RX   PubMed=7472412; DOI=10.1523/jneurosci.15-10-06498.1995;
RA   Ciabarra A.M., Sullivan J.M., Gahn L.G., Pecht G., Heinemann S.,
RA   Sevarino K.A.;
RT   "Cloning and characterization of chi-1: a developmentally regulated member
RT   of a novel class of the ionotropic glutamate receptor family.";
RL   J. Neurosci. 15:6498-6508(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), CHARACTERIZATION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Forebrain;
RX   PubMed=7472413; DOI=10.1523/jneurosci.15-10-06509.1995;
RA   Sucher N.J., Akbarian S., Chi C.L., Leclerc C.L., Awobuluyi M.,
RA   Deitcher D.L., Wu M.K., Yuan J.P., Jones E.G., Lipton S.A.;
RT   "Developmental and regional expression pattern of a novel NMDA receptor-
RT   like subunit (NMDAR-L) in the rodent brain.";
RL   J. Neurosci. 15:6509-6520(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Perez-Otano I., Contractor A., Schulteis C.T., Gibb A., Heinemann S.F.;
RT   "Altered single channel properties of NMDA receptors containing a novel
RT   NMDA receptor subunit splice variant, NR3A-2.";
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 839-1122 (ISOFORMS 1/2), TISSUE SPECIFICITY,
RP   AND DEVELOPMENTAL STAGE.
RC   TISSUE=Brain;
RX   PubMed=9891978; DOI=10.1016/s0014-5793(98)01590-7;
RA   Sun L., Margolis F.L., Shipley M.T., Lidow M.S.;
RT   "Identification of a long variant of mRNA encoding the NR3 subunit of the
RT   NMDA receptor: its regional distribution and developmental expression in
RT   the rat brain.";
RL   FEBS Lett. 441:392-396(1998).
RN   [5]
RP   CHARACTERIZATION, SUBCELLULAR LOCATION, IDENTIFICATION IN A COMPLEX WITH
RP   GRIN1; GRIN2A OR GRIN2B AND PPP2CB, AND INTERACTION WITH PPP2CB.
RX   PubMed=11588171; DOI=10.1523/jneurosci.21-20-07985.2001;
RA   Chan S.F., Sucher N.J.;
RT   "An NMDA receptor signaling complex with protein phosphatase 2A.";
RL   J. Neurosci. 21:7985-7992(2001).
RN   [6]
RP   CHARACTERIZATION, GLYCOSYLATION, SUBCELLULAR LOCATION, AND IDENTIFICATION
RP   IN A COMPLEX WITH GRIN1; GRIN2A OR GRIN2B.
RX   PubMed=11160393; DOI=10.1523/jneurosci.21-04-01228.2001;
RA   Perez-Otano I., Schulteis C.T., Contractor A., Lipton S.A., Trimmer J.S.,
RA   Sucher N.J., Heinemann S.F.;
RT   "Assembly with the NR1 subunit is required for surface expression of NR3A-
RT   containing NMDA receptors.";
RL   J. Neurosci. 21:1228-1237(2001).
RN   [7]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1; GRIN2A OR GRIN2B.
RX   PubMed=12391275; DOI=10.1124/mol.62.5.1119;
RA   Al-Hallaq R.A., Jarabek B.R., Fu Z., Vicini S., Wolfe B.B., Yasuda R.P.;
RT   "Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2
RT   subunits.";
RL   Mol. Pharmacol. 62:1119-1127(2002).
RN   [8]
RP   CHARACTERIZATION, ALTERNATIVE SPLICING (ISOFORMS 1 AND 2), AND
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1; GRIN2A OR GRIN2B.
RX   PubMed=11929923; DOI=10.1152/jn.00531.2001;
RA   Sasaki Y.F., Rothe T., Premkumar L.S., Das S., Cui J., Talantova M.V.,
RA   Wong H.-K., Gong X., Chan S.F., Zhang D., Nakanishi N., Sucher N.J.,
RA   Lipton S.A.;
RT   "Characterization and comparison of the NR3A subunit of the NMDA receptor
RT   in recombinant systems and primary cortical neurons.";
RL   J. Neurophysiol. 87:2052-2063(2002).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH GIT1.
RX   PubMed=24297929; DOI=10.1073/pnas.1312211110;
RA   Fiuza M., Gonzalez-Gonzalez I., Perez-Otano I.;
RT   "GluN3A expression restricts spine maturation via inhibition of GIT1/Rac1
RT   signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:20807-20812(2013).
RN   [10]
RP   FUNCTION, AND MUTAGENESIS OF 971-TYR--LEU-973 AND 1082-ASN--LEU-1115.
RX   PubMed=25009255; DOI=10.1523/jneurosci.5183-13.2014;
RA   Kehoe L.A., Bellone C., De Roo M., Zandueta A., Dey P.N., Perez-Otano I.,
RA   Muller D.;
RT   "GluN3A promotes dendritic spine pruning and destabilization during
RT   postnatal development.";
RL   J. Neurosci. 34:9213-9221(2014).
CC   -!- FUNCTION: NMDA receptor subtype of glutamate-gated ion channels with
CC       reduced single-channel conductance, low calcium permeability and low
CC       voltage-dependent sensitivity to magnesium. Mediated by glycine. During
CC       the development of neural circuits, plays a role in the synaptic
CC       refinement period, restricting spine maturation and growth. By
CC       competing with GIT1 interaction with ARHGEF7/beta-PIX, may reduce
CC       GIT1/ARHGEF7-regulated local activation of RAC1, hence affecting
CC       signaling and limiting the maturation and growth of inactive synapses
CC       (PubMed:24297929, PubMed:25009255). May also play a role in PPP2CB-
CC       NMDAR mediated signaling mechanism. {ECO:0000269|PubMed:24297929,
CC       ECO:0000269|PubMed:25009255}.
CC   -!- SUBUNIT: Forms heteromeric channel of a zeta subunit (GRIN1), a epsilon
CC       subunit (GRIN2A, GRIN2B, GRIN2C or GRIN2D) and a third subunit (GRIN3A
CC       or GRIN3B). Does not form functional homomeric channels. Found in a
CC       complex with GRIN1, GRIN2A or GRIN2B and PPP2CB. Probably interacts
CC       with PPP2CB. No complex with PPP2CB is detected when NMDARs are
CC       stimulated by NMDA. Interacts (via C-terminus) with GIT1, but not with
CC       GRIA1/GluA1, nor with synaptophysin/SYP; this interaction competes with
CC       GIT1 interaction with ARHGEF7/beta-PIX (PubMed:24297929).
CC       {ECO:0000269|PubMed:11160393, ECO:0000269|PubMed:11588171,
CC       ECO:0000269|PubMed:11929923, ECO:0000269|PubMed:12391275,
CC       ECO:0000269|PubMed:24297929}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11160393,
CC       ECO:0000269|PubMed:11588171}; Multi-pass membrane protein. Postsynaptic
CC       cell membrane. Postsynaptic density. Note=Enriched in postsynaptic
CC       plasma membrane and postsynaptic densities. Requires the presence of
CC       GRIN1 to be targeted at the plasma membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=NR3-long, NR3-l, NR3A-2;
CC         IsoId=Q9R1M7-1; Sequence=Displayed;
CC       Name=2; Synonyms=NR3-short, NR3-s;
CC         IsoId=Q9R1M7-2; Sequence=VSP_011512;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in olfactory
CC       bulb, frontal occipital, entorhinal and pyriform cortices, hippocampus,
CC       striatum, thalamus, cerebellum and spinal cord.
CC       {ECO:0000269|PubMed:7472412, ECO:0000269|PubMed:7472413,
CC       ECO:0000269|PubMed:9891978}.
CC   -!- DEVELOPMENTAL STAGE: Isoform 1 and isoform 2 are expressed in spinal
CC       cord, medulla, pons, tegmentum, thalamus and hypothalamus at 15 dpc
CC       onwards (PubMed:7472412, PubMed:7472413, PubMed:9891978). In the brain
CC       cortex and in the hippocampus, strongly expressed during periods of
CC       synapse/spine reorganization at postnatal day 8 (P8) to P15. Expression
CC       declines after P25 (at protein level) (PubMed:24297929).
CC       {ECO:0000269|PubMed:24297929, ECO:0000269|PubMed:7472412,
CC       ECO:0000269|PubMed:7472413, ECO:0000269|PubMed:9891978}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:11160393}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC 1.A.10.1)
CC       family. NR3A/GRIN3A subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L34938; AAA99501.1; -; mRNA.
DR   EMBL; U29873; AAB58957.1; -; mRNA.
DR   EMBL; AF073379; AAD41650.1; -; mRNA.
DR   EMBL; AF061945; AAD11811.1; -; mRNA.
DR   PIR; T31068; T31068.
DR   RefSeq; NP_001185512.1; NM_001198583.2. [Q9R1M7-2]
DR   RefSeq; NP_612555.1; NM_138546.2. [Q9R1M7-1]
DR   PDB; 2RC7; X-ray; 1.58 A; A/B=511-660, A/B=776-915.
DR   PDB; 2RC8; X-ray; 1.45 A; A/B=511-660, A/B=776-915.
DR   PDB; 2RC9; X-ray; 1.96 A; A/B=511-660, A/B=776-915.
DR   PDB; 4KCD; X-ray; 1.68 A; A/B=511-660, A/B=776-915.
DR   PDB; 8JF7; EM; 7.73 A; D=1-965.
DR   PDBsum; 2RC7; -.
DR   PDBsum; 2RC8; -.
DR   PDBsum; 2RC9; -.
DR   PDBsum; 4KCD; -.
DR   PDBsum; 8JF7; -.
DR   AlphaFoldDB; Q9R1M7; -.
DR   SMR; Q9R1M7; -.
DR   BioGRID; 251320; 2.
DR   CORUM; Q9R1M7; -.
DR   IntAct; Q9R1M7; 2.
DR   STRING; 10116.ENSRNOP00000007957; -.
DR   BindingDB; Q9R1M7; -.
DR   ChEMBL; CHEMBL342; -.
DR   DrugCentral; Q9R1M7; -.
DR   GlyCosmos; Q9R1M7; 11 sites, No reported glycans.
DR   GlyGen; Q9R1M7; 11 sites.
DR   iPTMnet; Q9R1M7; -.
DR   PhosphoSitePlus; Q9R1M7; -.
DR   PaxDb; 10116-ENSRNOP00000007957; -.
DR   ABCD; Q9R1M7; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000007957.7; ENSRNOP00000007957.6; ENSRNOG00000005723.8. [Q9R1M7-1]
DR   Ensembl; ENSRNOT00055034956; ENSRNOP00055028367; ENSRNOG00055020470. [Q9R1M7-1]
DR   Ensembl; ENSRNOT00060009329; ENSRNOP00060007005; ENSRNOG00060005622. [Q9R1M7-1]
DR   Ensembl; ENSRNOT00065017543; ENSRNOP00065013472; ENSRNOG00065010818. [Q9R1M7-1]
DR   GeneID; 191573; -.
DR   KEGG; rno:191573; -.
DR   UCSC; RGD:621704; rat. [Q9R1M7-1]
DR   AGR; RGD:621704; -.
DR   CTD; 116443; -.
DR   RGD; 621704; Grin3a.
DR   eggNOG; KOG1053; Eukaryota.
DR   GeneTree; ENSGT00940000158571; -.
DR   InParanoid; Q9R1M7; -.
DR   OMA; TIVMFGC; -.
DR   OrthoDB; 1034721at2759; -.
DR   PhylomeDB; Q9R1M7; -.
DR   TreeFam; TF314731; -.
DR   Reactome; R-RNO-9609736; Assembly and cell surface presentation of NMDA receptors.
DR   EvolutionaryTrace; Q9R1M7; -.
DR   PRO; PR:Q9R1M7; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:RGD.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0005262; F:calcium channel activity; ISO:RGD.
DR   GO; GO:0008066; F:glutamate receptor activity; IBA:GO_Central.
DR   GO; GO:0004970; F:glutamate-gated receptor activity; IDA:RGD.
DR   GO; GO:0016594; F:glycine binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IDA:UniProtKB.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; IDA:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0099565; P:chemical synaptic transmission, postsynaptic; ISO:RGD.
DR   GO; GO:0016358; P:dendrite development; ISO:RGD.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; ISO:RGD.
DR   GO; GO:0061000; P:negative regulation of dendritic spine development; IDA:UniProtKB.
DR   GO; GO:0048666; P:neuron development; IEP:RGD.
DR   GO; GO:0060134; P:prepulse inhibition; ISO:RGD.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0045471; P:response to ethanol; ISO:RGD.
DR   GO; GO:0048511; P:rhythmic process; IDA:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IBA:GO_Central.
DR   CDD; cd06377; PBP1_iGluR_NMDA_NR3; 1.
DR   CDD; cd13720; PBP2_iGluR_NMDA_Nr3; 1.
DR   Gene3D; 3.40.50.2300; -; 2.
DR   Gene3D; 3.40.190.10; Periplasmic binding protein-like II; 2.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_Glu_rcpt_met.
DR   InterPro; IPR015683; Ionotropic_Glu_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt_C.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   PANTHER; PTHR18966:SF397; GLUTAMATE RECEPTOR IONOTROPIC, NMDA 3A; 1.
DR   PANTHER; PTHR18966; IONOTROPIC GLUTAMATE RECEPTOR; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; Periplasmic binding protein-like I; 1.
DR   SUPFAM; SSF53850; Periplasmic binding protein-like II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell membrane; Coiled coil;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Magnesium; Membrane; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Signal; Synapse; Transmembrane; Transmembrane helix;
KW   Transport.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..1135
FT                   /note="Glutamate receptor ionotropic, NMDA 3A"
FT                   /id="PRO_0000011569"
FT   TOPO_DOM        24..674
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        675..695
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        696..748
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        749..769
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        770..930
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        931..951
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        952..1135
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          60..117
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          951..987
FT                   /note="PPP2CB binding site"
FT   REGION          1082..1115
FT                   /note="GIT1-binding"
FT                   /evidence="ECO:0000269|PubMed:24297929"
FT   COILED          1080..1129
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        145
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        264
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        275
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        285
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        296
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        300
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        426
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        439
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        549
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        565
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        886
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1003..1022
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7472412,
FT                   ECO:0000303|PubMed:7472413"
FT                   /id="VSP_011512"
FT   MUTAGEN         971..973
FT                   /note="YWL->AAA: Endocytosis-deficient. When transfected in
FT                   pyramidal neurons transfected, increases the rate of spine
FT                   elimination and reduction in the stability of preexisting
FT                   spines, compared to the wild-type protein. No effect on
FT                   spine growth rate."
FT                   /evidence="ECO:0000269|PubMed:25009255"
FT   MUTAGEN         1082..1115
FT                   /note="Missing: When expressed in pyramidal neurons,
FT                   increases spine stability and reduces spine elimination."
FT                   /evidence="ECO:0000269|PubMed:25009255"
FT   STRAND          513..519
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   TURN            523..525
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          526..529
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          540..544
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   HELIX           551..562
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          563..565
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   HELIX           570..572
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          573..578
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   HELIX           579..591
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          593..599
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   HELIX           615..621
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          626..628
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   HELIX           636..639
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          642..644
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          648..658
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   HELIX           783..786
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   HELIX           801..809
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   HELIX           811..817
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   HELIX           818..820
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          822..824
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   HELIX           825..833
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          834..836
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          840..845
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   HELIX           846..854
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          857..859
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          861..863
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          868..873
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   STRAND          876..878
FT                   /evidence="ECO:0007829|PDB:4KCD"
FT   HELIX           883..896
FT                   /evidence="ECO:0007829|PDB:2RC8"
FT   HELIX           899..907
FT                   /evidence="ECO:0007829|PDB:2RC8"
SQ   SEQUENCE   1135 AA;  127607 MW;  8EC1FEEAE50AB237 CRC64;
     MRRLSLWWLL SRVCLLLPPP CALVLAGVPS SSSHPQPCQI LKRIGHAVRV GAVHLQPWTT
     APRAASRAQE GGRAGAQRDD PESGTWRPPA PSQGARWLGS ALHGRGPPGS RKLGEGAGAE
     TLWPRDALLF AVENLNRVEG LLPYNLSLEV VMAIEAGLGD LPLMPFSSPS SPWSSDPFSF
     LQSVCHTVVV QGVSALLAFP QSQGEMMELD LVSSVLHIPV LSIVRHEFPR ESQNPLHLQL
     SLENSLSSDA DVTVSILTMN NWYNFSLLLC QEDWNITDFL LLTENNSKFH LESVINITAN
     LSSTKDLLSF LQVQMDNIRN STPTMVMFGC DMDSIRQIFE MSTQFGLSPP ELHWVLGDSQ
     NVEELRTEGL PLGLIAHGKT TQSVFEYYVQ DAMELVARAV ATATMIQPEL ALLPSTMNCM
     DVKTTNLTSG QYLSRFLANT TFRGLSGSIK VKGSTIISSE NNFFIWNLQH DPMGKPMWTR
     LGSWQGGRIV MDSGIWPEQA QRHKTHFQHP NKLHLRVVTL IEHPFVFTRE VDDEGLCPAG
     QLCLDPMTND SSMLDRLFSS LHSSNDTVPI KFKKCCYGYC IDLLEQLAED MNFDFDLYIV
     GDGKYGAWKN GHWTGLVGDL LSGTANMAVT SFSINTARSQ VIDFTSPFFS TSLGILVRTR
     DTAAPIGAFM WPLHWTMWLG IFVALHITAI FLTLYEWKSP FGMTPKGRNR NKVFSFSSAL
     NVCYALLFGR TAAIKPPKCW TGRFLMNLWA IFCMFCLSTY TANLAAVMVG EKIYEELSGI
     HDPKLHHPSQ GFRFGTVRES SAEDYVRQSF PEMHEYMRRY NVPATPDGVQ YLKNDPEKLD
     AFIMDKALLD YEVSIDADCK LLTVGKPFAI EGYGIGLPPN SPLTSNISEL ISQYKSHGFM
     DVLHDKWYKV VPCGKRSFAV TETLQMGIKH FSGLFVLLCI GFGLSILTTI GEHIVHRLLL
     PRIKNKSKLQ YWLHTSQRFH RALNTSFVEE KQPRSKTKRV EKSRWRRWTC KTEGDSELSL
     FPRSNLGPQQ LMVWNTSNLS HDNQRKYIFN DEEGQNQLGT QAHQDIPLPQ RRRELPASLT
     TNGKADSLNV TRSSVIQELS ELEKQIQVIR QELQLAVSRK TELEEYQKTN RTCES
//
